HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$9.22
Day range
$9.21 - $9.66
Year range
$8.82 - $21.00
Market cap
1.47B USD
Avg Volume
695.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 50.10M | 63.10% |
Net income | -108.73M | -286.31% |
Net profit margin | — | — |
Earnings per share | -0.71 | — |
EBITDA | -49.93M | -63.34% |
Effective tax rate | -0.25% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 453.98M | 22.08% |
Total assets | 496.20M | 16.41% |
Total liabilities | 27.12M | -7.75% |
Total equity | 469.08M | — |
Shares outstanding | 158.89M | — |
Price to book | 3.13 | — |
Return on assets | -24.06% | — |
Return on capital | -25.22% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -108.73M | -286.31% |
Cash from operations | -51.44M | -69.41% |
Cash from investing | 13.68M | 270.32% |
Cash from financing | -481.00K | -101.79% |
Net change in cash | -38.25M | -230.76% |
Free cash flow | -41.85M | — |
About
Founded
2019
Headquarters
Website
Employees
124